These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6188680)
1. Cellular response to basic protein and T suppressor cells in multiple sclerosis. Wicher V; Holub R Immunol Commun; 1982; 11(6):495-507. PubMed ID: 6188680 [TBL] [Abstract][Full Text] [Related]
2. Age-related reactivity of lymphocytes from multiple sclerosis patients to myelin basic protein. Wicher V; Olszewski W; Milgrom F Int Arch Allergy Appl Immunol; 1981; 66(2):136-41. PubMed ID: 6169648 [TBL] [Abstract][Full Text] [Related]
3. Dual response of lymphocytes from multiple sclerosis patients to myelin basic protein. Wicher V; Olszewski W; Milgrom F Clin Exp Immunol; 1979 Jul; 37(1):114-9. PubMed ID: 90569 [TBL] [Abstract][Full Text] [Related]
12. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocyte phenotype and function in multiple sclerosis. Hughes PJ; Compston DA J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1187-92. PubMed ID: 2976082 [TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis. Noronha A; Toscas A; Jensen MA Ann Neurol; 1992 Jan; 31(1):103-6. PubMed ID: 1371908 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. Vojdani A; Vojdani E; Cooper E J Intern Med; 2003 Oct; 254(4):363-74. PubMed ID: 12974875 [TBL] [Abstract][Full Text] [Related]
16. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis. Ilyas AA; Davison AN J Neurol Sci; 1983 Apr; 59(1):85-95. PubMed ID: 6189970 [TBL] [Abstract][Full Text] [Related]
17. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis. Trotter JL; Clifford DB; McInnis JE; Griffeth RC; Bruns KA; Perlmutter MS; Anderson CB; Collins KG; Banks G; Hicks BC Ann Neurol; 1989 Feb; 25(2):172-8. PubMed ID: 2521993 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. Colombo E; Banki K; Tatum AH; Daucher J; Ferrante P; Murray RS; Phillips PE; Perl A J Clin Invest; 1997 Mar; 99(6):1238-50. PubMed ID: 9077532 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis. Utz U; Brooks JA; McFarland HF; Martin R; Biddison WE Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5567-71. PubMed ID: 7515505 [TBL] [Abstract][Full Text] [Related]
20. In vitro effects of 4-hydroperoxycyclophosphamide on concanavalin A-induced human suppressor T cells. Klajman A; Drucker I; Manor Y; Ben-Efraim S Cancer Immunol Immunother; 1984; 18(2):113-7. PubMed ID: 6239682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]